The Prasol Chemicals IPO is an upcoming Mainboard IPO of specialty chemicals manufacturer Prasol Chemicals Limited. The company manufactures more than 150 specialty chemicals used across pharmaceuticals, agrochemicals, paints, inks, construction, adhesives, performance chemicals, and home and personal care.
The Prasol Chemicals IPO will open for subscription on September 8, 2026, and close on September 10, 2026. The issue size is ₹500 crore, comprising a fresh issue of ₹80 crore and an Offer for Sale (OFS) of ₹420 crore.
The Prasol Chemicals IPO price band is fixed at ₹643–₹676 per share, with a lot size of 22 shares. Retail investors need a minimum investment of ₹14,872 at the upper price band. The shares are proposed to list on BSE and NSE on September 16, 2026.
Prasol Chemicals IPO Details
Particulars
Details
IPO Type
Mainboard Book Build Issue
Issue Size
₹500 Crore
Fresh Issue
₹80 Crore
Offer for Sale
₹420 Crore
IPO Open Date
8 Sep 2026
IPO Close Date
10 Sep 2026
Allotment Date
11 Sep 2026
Listing Date
16 Sep 2026
Price Band
₹643–₹676
Face Value
₹2
Lot Size
22 Shares
Minimum Investment
₹14,872
Listing
BSE & NSE
Registrar
KFin Technologies Ltd.
Lead Manager
DAM Capital Advisors Ltd.
Prasol Chemicals IPO Timeline
Event
Date
IPO Opens
8 Sep 2026
IPO Closes
10 Sep 2026
Basis of Allotment
11 Sep 2026
Refunds
15 Sep 2026
Demat Credit
15 Sep 2026
Listing
16 Sep 2026
Dates are tentative and may change.
Prasol Chemicals IPO GMP
The latest Prasol Chemicals IPO GMP is ₹50 as of September 8, 2026. At the upper price band of ₹676, the GMP indicates an estimated listing price of ₹726, implying a potential gain of around 7.40% over the issue price.
Date
IPO Price
GMP
Estimated Listing Price
Estimated Gain
8 Sep 2026
₹676
₹50
₹726
7.40%
7 Sep 2026
₹676
₹90
₹766
13.31%
6 Sep 2026
₹676
₹115
₹791
17.01%
5 Sep 2026
₹676
₹125
₹801
18.49%
4 Sep 2026
₹676
₹165
₹841
24.41%
3 Sep 2026
₹676
₹14
₹690
2.07%
For one lot of 22 shares, a GMP of ₹50 translates into an indicative profit of ₹1,100.
However, GMP operates in an unofficial and unregulated market. It can change significantly before listing and does not guarantee the actual listing price or returns.
Prasol Chemicals IPO Subscription Status
The IPO has opened . Therefore, live subscription data is 0.18x.
Category
Subscription
QIB
0.00x
NII
0.10x
S-NII
0.22x
B-NII
0.05x
Retail
0.31x
Total
0.18x
Day-wise Subscription Trend
Day
QIB
NII
S-NII
N-NII
Retail
Total
Day 3 – 10 Sep
–
–
–
–
–
–
Day 2 – 9 Sep
–
–
–
–
–
–
Day 1 – 8 Sep
0.00x
0.10x
0.22x
0.05x
0.31x
0.18x
Subscription figures will be updated once bidding begins.
What is the Current Subscription Data for Prasol Chemicals IPO?
Since the IPO is yet to open, the current subscription data for Prasol Chemicals IPO is not available.
Category
Shares Offered
Shares Bid
Bid Amount (₹ Cr)
QIB
14,79,289
0
0.00
NII
11,09,466
1,15,324
7.80
-- Small NII
3,69,822
80,806
5.46
-- Big NII
7,39,644
34,518
2.33
RII
25,88,753
8,07,004
54.55
Total
51,77,508
9,22,328
62.35
The final subscription level can provide an indication of investor demand, but subscription numbers alone should not be considered sufficient for making an investment decision.
Prasol Chemicals IPO Lot Size
The minimum bid is 22 shares and bids can be placed in multiples of 22.
Category
Lots
Shares
Investment
Retail Minimum
1
22
₹14,872
Retail Maximum
13
286
₹1,93,336
S-HNI Minimum
14
308
₹2,08,208
S-HNI Maximum
67
1,474
₹9,96,424
B-HNI Minimum
68
1,496
₹10,11,296
Prasol Chemicals IPO Reservation
Investor Category
Reservation
QIB
Not more than 50%
Retail
Not less than 35%
NII
Not less than 15%
About Prasol Chemicals
Prasol Chemicals Limited operates in the specialty chemicals industry and manufactures more than 150 specialty chemical products.
Its portfolio includes 21 acetone-based chemicals, 53 phosphorous-based chemicals and 76 other specialty chemicals, including surfactants, esters and acids.
The company's products cater to five major application industries:
Performance chemicals
Paints, inks, construction and adhesives
Pharmaceuticals
Agrochemicals
Home and personal care
Prasol Chemicals operates manufacturing facilities in Khopoli and Mahad, with an aggregate manufacturing capacity of approximately 87,914 MT per year.
As of July 31, 2025, the company served 1,107 customers across 69 countries. Its customer base includes companies such as Alembic Pharmaceuticals, Lubrizol India, Rossari Biotech, Clean Science, Gharda Chemicals, Croda India, Supriya Lifescience and Yasho Industries.
The company is also recognised as a 3 Star Export House and has a distribution network across APAC, North and South America, and Europe.
Prasol Chemicals Product Portfolio
The company has a diversified specialty chemical portfolio:
Acetone-based chemicals: Used across multiple industrial applications.
Phosphorous-based chemicals: Used in specialty chemical and industrial applications.
Performance chemicals: Includes products for lubricant and mining additives.
PICA products: Chemicals used in paints, inks, construction and adhesives.
Pharmaceutical and agrochemical chemicals: Products supplied to pharmaceutical and agricultural chemical manufacturers.
Home and personal care chemicals: Specialty ingredients for consumer applications.
Competitive Strengths
Diversified portfolio of more than 150 specialty chemicals.
Presence across multiple end-user industries.
Strong R&D capabilities and product development pipeline.
Customer base spread across 69 countries.
Long-standing relationships with domestic and international customers.
Experienced management team.
Consistent improvement in financial performance.
Prasol Chemicals IPO Objectives
The company plans to use the net IPO proceeds mainly for debt repayment.
IPO Objective
Amount
Repayment/Prepayment of Borrowings
₹60 Crore
General Corporate Purposes
Balance Amount
Total Identified
₹60 Crore
Debt reduction could help lower the company's interest burden and strengthen its balance sheet.
Prasol Chemicals Financial Performance
₹ Crore
Particulars
FY24
FY25
FY26
Total Income
887.56
1,015.54
1,237.85
EBITDA
60.53
87.77
139.32
Profit After Tax
18.13
43.57
83.12
Total Assets
626.36
723
839.28
Net Worth
325.84
367
448.51
Total Borrowings
82.07
101.05
110.06
Prasol Chemicals reported strong growth in FY26. Total income increased from ₹1,015.54 crore in FY25 to ₹1,237.85 crore, representing approximately 22% growth. PAT almost doubled from ₹43.57 crore to ₹83.12 crore, an increase of around 91%. EBITDA also rose from ₹87.77 crore to ₹139.32 crore. The company's borrowings increased moderately to ₹110.06 crore, remaining significantly lower than its net worth.
Key Financial Ratios
KPI
FY26
ROE
20.37%
ROCE
22.43%
Debt/Equity
0.19x
RoNW
18.53%
PAT Margin
6.74%
EBITDA Margin
11.30%
The company reported a 20.37% ROE and 22.43% ROCE in FY26. Its debt-to-equity ratio of around 0.19x indicates relatively moderate leverage.
Prasol Chemicals IPO Valuation
Metric
Pre-IPO
EPS
₹14.33
NAV
₹77.33
Promoter Holding
89.20%
Post-IPO promoter holding is expected to reduce to 77.51%.
At the upper price band of ₹676, investors should compare Prasol's implied valuation with listed specialty chemical companies and assess whether the company's earnings growth can support the IPO valuation.
Promoter holding is expected to decline from 89.20% before the IPO to 77.51% after the issue
Risks Investors Should Consider
Specialty chemical competition:
The company operates in a competitive industry with both domestic and international players.
Raw material volatility:
Changes in raw material prices can affect production costs and margins.
Export exposure:
With customers across 69 countries, the company is exposed to currency movements, international regulations and global demand.
Customer and industry concentration:
Demand is linked to several end-use industries, including pharmaceuticals, agrochemicals and paints.
OFS-heavy issue:
A large portion of the IPO consists of an OFS of ₹420 crore, while only ₹80 crore represents fresh capital for the company.
Should You Invest in Prasol Chemicals IPO?
Prasol Chemicals presents a combination of strong earnings growth, diversified products, international presence and moderate leverage.
The company grew revenue by around 22% and PAT by around 91% in FY26. Its ROE of 20.37% and ROCE of 22.43% also indicate healthy profitability.
The key points to watch are the IPO valuation, the large OFS component and the company's ability to sustain its recent earnings growth.
The latest GMP of ₹50 indicates positive grey-market sentiment, but investors should not base their decision solely on GMP. The company's financial performance, valuation, industry outlook and risk factors should be evaluated before subscribing.
Prasol Chemicals IPO Allotment Status
The Prasol Chemicals IPO allotment is expected on September 11, 2026.
Investors can check their allotment status through the official IPO registrar, KFin Technologies Ltd.
How to Check Prasol Chemicals IPO Allotment?
Visit the KFin Technologies IPO allotment page.
Select Prasol Chemicals IPO.
Choose PAN, application number or DP ID/client ID.
Enter the required details.
Click on Search.
Your allotment status will be displayed.
Investors may also receive allotment updates through their bank, broker, email or SMS
The Prasol Chemicals IPO is a ₹500 crore Mainboard issue opening from September 8 to September 10, 2026.
The price band is ₹643–₹676, with a lot size of 22 shares and a minimum retail investment of ₹14,872.
The company has a diversified specialty chemicals portfolio of more than 150 products, serves 1,107 customers across 69 countries, and reported ₹1,237.85 crore total income and ₹83.12 crore PAT in FY26.
The latest GMP of ₹50 indicates an estimated listing price of ₹726 at the upper price band, but GMP is unofficial and can change.
For investors, the key positives are strong earnings growth, diversified end markets, international presence and moderate debt. Key concerns include valuation, competition and the large OFS component.
FAQs
What is the Prasol Chemicals IPO issue size?
The Prasol Chemicals IPO issue size is ₹500 crore, comprising ₹80 crore fresh issue and ₹420 crore OFS.
What is the Prasol Chemicals IPO price band?
The price band is ₹643 to ₹676 per share.
What is the Prasol Chemicals IPO GMP today?
The latest supplied GMP is ₹50 as of September 8, 2026.
What is the Prasol Chemicals IPO lot size?
The lot size is 22 shares and the minimum investment is ₹14,872 at the upper price band.
When will the Prasol Chemicals IPO open?
The IPO opens on September 8, 2026.
When will Prasol Chemicals IPO close?
The IPO closes on September 10, 2026.
When is Prasol Chemicals IPO allotment?
The basis of allotment is expected on September 11, 2026.
When will Prasol Chemicals shares list?
The shares are expected to list on September 16, 2026 on BSE and NSE.
Who is the registrar of Prasol Chemicals IPO?
KFin Technologies Ltd. is the IPO registrar.
What is Prasol Chemicals' FY26 profit?
The company reported ₹83.12 crore PAT in FY26.
What is Prasol Chemicals' FY26 revenue?
Prasol Chemicals reported ₹1,237.85 crore total income in FY26.
Disclaimer
This article is for informational and educational purposes only and does not constitute investment advice. IPO dates, GMP, subscription figures, valuations and other details may change. Grey Market Premium is unofficial and does not guarantee listing gains or future returns. Investors should read the company's RHP and assess all relevant risks before making an investment decision.
Author: Komal Bhatt
Komal Bhatt is a finance content writer at InvestKraft, specialising in well-researched articles on financial products, stock markets, and investment opportunities, with a particular focus on unlisted shares.
She holds a Master’s degree in Commerce from the University of Delhi, which gives her a solid academic foundation in finance and business. With over three years of hands-on experience in creating digital finance content, Komal has developed a clear understanding of investor needs through her work on wealth management, NISM certification programs, and market education materials.
Komal is passionate when it comes to breaking down complex financial concepts into simple, accurate and actionable insights. Her goal is to help everyday investors understand markets better and make more informed decisions based on reliable, research-backed information.